Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk - Test2 - elhamkhani - TriplyDB

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk

http://www.wikidata.org/entity/Q33715302

about

Natriuretic Peptides: The Case of Prostate Cancer.Blood Pressure Profile and N-Terminal-proBNP Dynamics in Response to Intravenous Methylprednisolone Pulse Therapy of Severe Graves' Orbitopathy

P2860

Q47849831-F5B44B96-449A-4C59-82BC-61747F30826A Q59134155-3F4299CE-A4D1-469B-8124-039FCDA98F43

P2860

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk

http://www.wikidata.org/entity/Q33715302

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk

@ast

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk

@en

type

label

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk

@ast

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk

@en

prefLabel

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk

@ast

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk

@en

P1433

Q33715302-3707A340-F3FC-467A-B751-7321DEF178CF

P1476

Q33715302-587F63CC-67F5-4B2F-B780-0211AA1C3240

P2093

Q33715302-225BFBCD-F20B-43BD-B4D3-034C975A6066

Q33715302-5A0F15DD-E971-40D7-90B2-AFBC96BAC50B

Q33715302-AC732FCF-395D-4205-A58E-724F30F549CB

Q33715302-D1271CA3-6E8C-4B91-8DBD-0CE89D00F3D3

P275

Q33715302-6600FE4E-D6EF-497F-B571-576D13F04656

P2860

Q33715302-0104AD31-5830-4905-87F0-A35482A75577

Q33715302-04743D94-68D7-41A5-AEFB-F83C39E8646F

Q33715302-0658372D-ABDD-49A1-8A1C-E8451DEBF940

Q33715302-075283F8-0013-4E31-8ECA-0C9A40F1A7AA

Q33715302-0A8CCE21-7AFA-430D-8F3F-BF48C21C0BC7

Q33715302-0BB63035-962B-4DBA-9DD5-58E89829EAA2

Q33715302-0BD8C8B4-94BC-4491-B796-469351CE1B4D

Q33715302-0D48FD82-39BC-4998-B584-98106F869038

Q33715302-0F0DA1DE-FB98-4916-8224-36DED26E7F9D

Q33715302-115F87B3-16AC-41D4-982E-E4A5D18C3284

P2888

Q33715302-99FD9302-CB7A-484D-AC45-DCB25BBF308C

P304

Q33715302-2C67CBA0-A67F-461C-919A-A7D2F4C7A3D9

P31

Q33715302-70573096-2208-468A-88F6-58EB8BAA51C4

Q33715302-93F8E6FE-FBBE-45E0-87D5-0E3129EAFE44

P356

Q33715302-A8BDE338-F0CB-45CA-B01C-734CF3E3C3DC

P433

Q33715302-05C749A9-A442-45D1-9CE2-FA2BE053C41E

P478

Q33715302-B223A964-BC3E-4786-A89E-3EA986A534C9

P50

Q33715302-1A2FC0B2-8462-4E5D-8265-CA3C83385DD3

Q33715302-3E383E0E-0703-4D31-9207-C87A0CE27AB7

P5008

Q33715302-2D22001D-E990-4535-A0FB-C12B04DAC854

P577

Q33715302-0EF0015F-C3A8-44DB-8F63-4A055942E59A

Q33715302-FE132691-DCA1-4D08-96AE-C09864F7D1BB

P698

Q33715302-1240C2B5-AE6D-4012-8257-53591C7EFDB8

P921

Q33715302-11DB7F54-B785-4C65-93EA-82E260CBF267

Q33715302-4FA40567-0F6F-4241-96E0-9E8285ABEBEE

Q33715302-5EC1F783-F276-47E5-AF31-8E400E16F43F

Q33715302-C5673AE1-29A6-4ADD-8547-4A9C85788E75

Q33715302-FAFD8133-4C3C-4DC1-A86F-0B58C3793CEF

P932

Q33715302-0BE7195F-D9F8-438C-88D8-FEE844F9DCC3

P356

S40292-017-0196-1

P1433

High Blood Pressure & Cardiovascular Prevention

P1476

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk

@en

P2093

Federico Giulietti

http://www.w3.org/2001/XMLSchema#string

Guido Cocci

http://www.w3.org/2001/XMLSchema#string

Marica Bordicchia

http://www.w3.org/2001/XMLSchema#string

Paolo Balietti

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan

Mechanisms of aging-related impairment of brown adipocyte development and function

Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype

Angiotensin-neprilysin inhibition versus enalapril in heart failure

The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system

Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013

Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome.

P2888

s40292-017-0196-1

P304

115-126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40292-017-0196-1

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Riccardo Sarzani

Francesco Spannella

P5008

P577

2017-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28378069

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

arterial hypertension

nerve tissue proteins

P932

5440492

http://www.w3.org/2001/XMLSchema#string